Noom Launches Proactive Health Microdose GLP-1 Program for Lower BMI Group Beyond Obesity Labels

Noom launched Proactive Health Microdose GLP-1Rx, available to adults with BMI 21 or higher, expanding beyond FDA obesity drug labels (typically BMI 30+ or 27+ with conditions)13.

Program combines personalized microdoses (starting at 25% of standard lowest dose), at-home biomarker testing, and Noom's behavior coaching for metabolic health and longevity123.

Aims to prevent chronic disease with low-dose GLP-1s for cardiometabolic benefits without rapid weight loss focus; costs $149/month or starts at $99135.

Real-world data shows metabolic improvements; claims up to 17 pounds loss in 60 days for top users358.

Dr. Jeffrey Egler emphasized structure with medication to prevent weight regain post-taper2.

Sources:

1. https://hitconsultant.net/2025/12/15/noom-pivots-to-longevity-new-program-combines-microdose-glp-1s-with-at-home-biomarker-testing/

2. https://www.noom.com/blog/weight-management/how-nooms-microdose-glp-1-program-helps-prevent-weight-regain-today-show/

3. https://www.noom.com/in-the-news/proactive-health-starts-here/

5. https://www.noom.com/med/glp1-microdose/

8. https://pharmaphorum.com/news/noom-expands-its-glp-1-range-microdose-package